Table 2.
Global assessment of efficacy and tolerability in three study groups
| Total (n=30), n (%) | Yogic relaxation (n=10), n (%) | Alprazolam (n=10), n (%) | Placebo (n=10), n (%) | P | |
|---|---|---|---|---|---|
| Global assessment of efficacy | |||||
| Excellent | 12 (40) | 9 (90) | 2 (20) | 1 (10) | 0.000 |
| Good | 5 (16.7) | 1 (10) | 4 (40) | 0 | |
| Moderate | 6 (20) | 0 | 3 (30) | 3 (30) | |
| Poor | 7 (23.3) | 0 | 1 (10) | 6 (60) | |
| Global assessment of tolerability | |||||
| Excellent | 24 (80) | 9 (90) | 7 (70) | 8 (80) | 0.535 |
| Good | 6 (20) | 1 (10) | 3 (30) | 2 (20) |